Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients with Moderate-to-Severe Psoriasis. (2018). SKIN The Journal of Cutaneous Medicine, 2(S1), S1. https://doi.org/10.25251/skin.2.supp.1